Early identification of treatment response to neoadjuvant systemic therapy (NAST) in Triple Negative Breast Cancer (TNBC) patients is important for appropriate treatment selection and response monitoring. In this study we evaluated the ability of a radiomic model extracted from a novel sequence, Magnetic Resonance Image Compilation (MAGIC), acquired before treatment initiation, to predict NAST response in TNBC. Our results showed that the radiomic signature derived from MAGIC maps (T1, PD and T2) can help differentiate responders from non-responders at baseline evaluation.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords